Evolving Regulatory Environment for Laboratory Developed Tests (LDTs)

Evolving Regulatory Environment for Laboratory Developed Tests (LDTs)

Tuesday, March 19th, 2019 at 12 pm EST (US & Canada)

Presented by

Thomas N. Denny, M Phil, MSc.

Professor of Medicine and Chief Operating Office

Duke Human Vaccine Institute, Duke University School of Medicine

Moderated by

Paul K. Wallace, PhD

Director of Flow and Image Cytometry Department

Roswell Park Cancer Comprehensive Center, Buffalo, NY


About the Faculty

Mr. Denny is the Chief Operating Officer of the Duke Human Vaccine Institute (DHVI) and a Professor of Medicine and a Member of the Duke Global Health Institute at Duke University. He is also the director, of the Immunology and Virology Quality assessment Center. As the Chief Operating Officer of the DHVI, Mr. Denny has administrative oversight of a research portfolio including discovery and translational programs. He has over 30 years of immunology and virology experience studying host defense mechanisms. As part of the HIV clinical trials program, he has served on numerous committees for the NIH over the last two decades. Previously, he served on an expert panel for the CDC helping to establish clinical laboratory guidelines for using T-cell immunophenotyping in patients with HIV disease. In 1997, he received an NIH HIV Innovative Vaccine Grant award to study a new method of vaccine delivery. He is the principal investigator of the NIH-NIAID Division of AIDS Immunology Quality Assurance (IQA) Program; NIH NIAID DAIDS External Quality Assessment Proficiency Oversight Laboratory (EQAPOL) and NIH-NIAID DAIDS Non-Human Primate Virology Reference Laboratory. In 2002, he was a Robert Wood Johnson Health Policy Fellow and served on the US Senate HELP Committee staffing a number of health and science legislative issues. Mr. Denny has authored or co-authored more than 150 peer-reviewed papers and has served on the editorial board of Clinical and Diagnostic Laboratory Immunology, Communications in Cytometry and Clinical and Applied Immunology Reviews.

Webinar Summary

The history of the development of the current regulatory environment for laboratory developed tests (e.g., home brews). There will also be an outline of legislative proposals that are being suggested by current members of the house and senate, which, if enacted, could change what researchers do significantly. 

Learning Objectives

-Understand how legislation evolves and the process of enacting it

-Understand the development and impact of rules on how legislation becomes a working practice

-Understand the impact of new legislation and rules on how you practice laboratory medicine

-Develop an understanding on how to get involved

Who Should Attend

Those responsible for developing or using LDTs, managing laboratories, and maintaining laboratory accreditations

Seminar Information
Date Presented:
March 19, 2019 12:00 PM Eastern
1 hour
Evolving Regulatory Environment for Laboratory Developed Tests (LDTs)
Individual topic purchase: Selected
American Society for Clinical Pathology
CMLE: 1.00
ISAC Member Price: $0.00
Non-Member Price:$0.00